FDA Approved: REGADENOSON — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved Regadenoson via an original application for Eugia US LLC (ANDA216437), enabling a generic version of Regadenoson for pharmacologic stress testing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Ischemia

Drugs mentioned

• Regadenoson (Regadenoson)

Snippet

ORIG AP for REGADENOSON (REGADENOSON)